#Coronavirus Disease Research #References (by AMEDEO, March 1 '25)

 

Am J Respir Crit Care Med

1. KERWIN E, Yang T, Su N, Guo J, et al
   Rademikibart Treatment for Moderate-to-Severe, Uncontrolled Asthma: A Phase 2B Randomized Trial.
   Am J Respir Crit Care Med. 2025 Feb 25. doi: 10.1164/rccm.202409-1708.
   PubMed         Abstract available
   
   

   
   Antiviral Res

2. BRUN J, Arman BY, Hill ML, Kiappes JL, et al
   Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals.
   Antiviral Res. 2025 Feb 23:106123. doi: 10.1016/j.antiviral.2025.106123.
   PubMed         Abstract available
   
   

   
   BMJ

3. MACINTYRE CR, Chughtai AA, Kunasekaran M, Tawfiq E, et al
   The role of masks and respirators in preventing respiratory infections in healthcare and community settings.
   BMJ. 2025;388:e078573.
   PubMed         Abstract available
   
   

   
   Emerg Infect Dis

4. UJIIE M
   Emerging Trends in Streptococcal Toxic Shock Syndrome, Japan.
   Emerg Infect Dis. 2025;31.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

5. STONE EC, Okasako-Schmucker DL, Taliano J, Schaefer M, et al
   Risk period for transmission of SARS-CoV-2 and seasonal influenza: a rapid review.
   Infect Control Hosp Epidemiol. 2025 Feb 24:1-9. doi: 10.1017/ice.2025.
   PubMed         Abstract available
   
   
6. BREKELMANS MACM, Vlek ALM, van Dijk Y, Smilde AE, et al
   Automated surveillance of hospital-onset bacteremia and fungemia: feasibility and epidemiological results from a Dutch multicenter study.
   Infect Control Hosp Epidemiol. 2025 Feb 26:1-9. doi: 10.1017/ice.2025.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

7. JOO H, Kim E, Huh K, Bae GH, et al
   Risk of Post-Acute Sequelae of COVID-19 and Oral Antivirals in Adults Aged Over 60 years: A Nationwide Retrospective Cohort Study.
   Int J Infect Dis. 2025 Feb 24:107850. doi: 10.1016/j.ijid.2025.107850.
   PubMed         Abstract available
   
   

   
   J Virol

8. QIN W, Kong N, Xie S, Liu H, et al
   RNASEK interacting with PEDV structural proteins facilitates virus entry via clathrin-mediated endocytosis.
   J Virol. 2025;99:e0176024.
   PubMed         Abstract available
   
   
9. LI W, Hangalapura BN, van den Elzen P, van den Born E, et al
   Spike gene variability in porcine epidemic diarrhea virus as a determinant for virulence.
   J Virol. 2025 Feb 26:e0216524. doi: 10.1128/jvi.02165.
   PubMed         Abstract available
   
   
10. KEEP S, Foldes K, Dowgier G, Freimanis G, et al
    Recombinant infectious bronchitis virus containing mutations in non-structural proteins 10, 14, 15, and 16 and within the macrodomain provides complete protection against homologous challenge.
    J Virol. 2025 Feb 27:e0166324. doi: 10.1128/jvi.01663.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

11. FOCOSI D, Casadevall A
    Sipavibart: when a success changes into a failure.
    Lancet Infect Dis. 2025 Feb 24:S1473-3099(24)00812.
    PubMed        
    
    
12. HAIDAR G, Thomas S, Loubet P, Baker RI, et al
    Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.
    Lancet Infect Dis. 2025 Feb 24:S1473-3099(24)00804.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

13. FRUTOS AM, Cleary S, Reeves EL, Ahmad HM, et al
    Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:83-90.
    PubMed         Abstract available
    
    
14. LINK-GELLES R, Chickery S, Webber A, Ong TC, et al
    Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged >/=18 Years - VISION and IVY Networks, September 2024-January 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:73-82.
    PubMed         Abstract available
    
    

    
    Nature

15. SOWEMIMO A
    The racial injustice laid bare by COVID must not be forgotten.
    Nature. 2025;638:883-884.
    PubMed        
    
    
16. SMITH J
    Daily briefing: Where did COVID-19 come from? Evidence points to raccoon dogs.
    Nature. 2025 Feb 21. doi: 10.1038/d41586-025-00583.
    PubMed        
    
    

    
    Radiology

17. POHLER GH, Voskrebenzev A, Heinze ML, Skeries V, et al
    Phase-resolved Functional Lung MRI Reveals Distinct Lung Perfusion Phenotype in Children and Adolescents with Post-COVID-19 Condition.
    Radiology. 2025;314:e241596.
    PubMed         Abstract available
    
    
18. PARRAGA G, Svenningsen S
    Seeing the Unseen: Pulmonary MRI in Children with Post-COVID-19 Condition.
    Radiology. 2025;314:e250127.
    PubMed        
    
    

    
    Travel Med Infect Dis

19. FAGONI N, Stirparo G, Sechi GM, Comelli A, et al
    The leading "blended" civil medical evacuation operation (MEDEVAC) in unforeseen health emergency. From military use to civil development.
    Travel Med Infect Dis. 2025;63:102794.
    PubMed         Abstract available
    
    
20. SAHIN OE, Kalay Z, Sari ND, Batirel A, et al
    Malaria in Turkey: A comprehensive analysis of diagnosis, treatment, and the impact of COVID-19, ten years after malaria elimination (2012-2023).
    Travel Med Infect Dis. 2025;64:102819.
    PubMed         Abstract available